PUBLISHER: IMARC | PRODUCT CODE: 1541515
PUBLISHER: IMARC | PRODUCT CODE: 1541515
Xerostomia Therapeutics Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032
The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032.
Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer's disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function.
Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:
The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren's syndrome, Alzheimer's diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type and distribution channel.
Breakup by Type:
Artificial Saliva/Saliva Substitutes
Salivary Stimulants
Breakup by Drug Type:
OTC
Prescription
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).
Key Questions Answered in This Report
- 1. How big is the global xerostomia (dry mouth disease) therapeutics market?
- 2. What is the expected growth rate of the global xerostomia (dry mouth disease) therapeutics market during 2024-2032?
- 3. What are the key factors driving the global xerostomia (dry mouth disease) therapeutics market?
- 4. What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
- 5. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on type?
- 6. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the drug type?
- 7. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the distribution channel?
- 8. What are the key regions in the global xerostomia (dry mouth disease) therapeutics market?
- 9. Who are the key players/companies in the global xerostomia (dry mouth disease) therapeutics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Xerostomia (Dry Mouth Disease) Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Artificial Saliva/Saliva Substitutes
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Salivary Stimulants
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 OTC
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Prescription
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Pharmacy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3M Company
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Biotene (GSK plc)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Parnell Pharmaceuticals Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Quest Products LLC
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Saliwell Ltd
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Sun Pharmaceutical Industries Limited
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.1 3M Company
List of Figures
- Figure 1: Global: Xerostomia Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2023
- Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2023
- Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2023
- Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2023
- Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
- Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
- Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Xerostomia Therapeutics Market: Key Industry Highlights 2023 and 2032
- Table 2: Global: Xerostomia Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Xerostomia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
- Table 4: Global: Xerostomia Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 5: Global: Xerostomia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Xerostomia Therapeutics Market: Competitive Structure
- Table 7: Global: Xerostomia Therapeutics Market: Key Players
